Skip to main content
. 2022 May 18;12:8313. doi: 10.1038/s41598-022-12003-z

Table 1.

Total number (N) of patients and median FBA concentrations with IQR in each patient cohort based on their SeHCAT result. BAD idiopathic BAD, PC post-cholecystectomy, CD post-operative Crohn’s disease patients, CG SeHCAT negative control group.

SeHCAT result BAD PC CD CG
N FBA N FBA N FBA N FBA
< 5% 7 8.2 (4.2–16.9) 8 5.6 (4.0–8.1) 16 11.8 (10.1–16.2)
5–10% 12 2.1 (1.4–5.0) 9 3.2 (2.0–6.2)
10–15% 14 3.2 (2.5–4.8) 3 2.8 (1.3–4.3)
> 15% 7 2.5 (1.1–4.0) 1 12.5 36 2.8 (1.6–4.2)